Literature DB >> 31094741

Argon Inhalation for 24 Hours After Onset of Permanent Focal Cerebral Ischemia in Rats Provides Neuroprotection and Improves Neurologic Outcome.

Shuang Ma1,2, Dongmei Chu2,3, Litao Li2,4, Jennifer A Creed2, Yu-Mi Ryang5, Huaxin Sheng2, Wei Yang2, David S Warner2, Dennis A Turner2, Ulrike Hoffmann2.   

Abstract

OBJECTIVES: We tested the hypothesis that prolonged inhalation of 70% argon for 24 hours after in vivo permanent or temporary stroke provides neuroprotection and improves neurologic outcome and overall recovery after 7 days.
DESIGN: Controlled, randomized, double-blinded laboratory study.
SETTING: Animal research laboratories.
SUBJECTS: Adult Wistar male rats (n = 110).
INTERVENTIONS: Rats were subjected to permanent or temporary focal cerebral ischemia via middle cerebral artery occlusion, followed by inhalation of 70% argon or nitrogen in 30% oxygen for 24 hours. On postoperative day 7, a 48-point neuroscore and histologic lesion size were assessed.
MEASUREMENTS AND MAIN RESULTS: After argon inhalation for 24 hours immediately following "severe permanent ischemia" induction, neurologic outcome (neuroscore, p = 0.034), overall recovery (body weight, p = 0.02), and infarct volume (total infarct volume, p = 0.0001; cortical infarct volume, p = 0.0003; subcortical infarct volume, p = 0.0001) were significantly improved. When 24-hour argon treatment was delayed for 2 hours after permanent stroke induction or until after postischemic reperfusion treatment, neurologic outcomes remained significantly improved (neuroscore, p = 0.043 and p = 0.014, respectively), as was overall recovery (body weight, p = 0.015), compared with nitrogen treatment. However, infarct volume and 7-day mortality were not significantly reduced when argon treatment was delayed.
CONCLUSIONS: Neurologic outcome (neuroscore), overall recovery (body weight), and infarct volumes were significantly improved after 24-hour inhalation of 70% argon administered immediately after severe permanent stroke induction. Neurologic outcome and overall recovery were also significantly improved even when argon treatment was delayed for 2 hours or until after reperfusion.

Entities:  

Year:  2019        PMID: 31094741      PMCID: PMC6629476          DOI: 10.1097/CCM.0000000000003809

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  36 in total

1.  Modulation by the noble gas argon of the catalytic and thrombolytic efficiency of tissue plasminogen activator.

Authors:  Hélène N David; Benoît Haelewyn; Jean-Jacques Risso; Jacques H Abraini
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-11-11       Impact factor: 3.000

2.  Isoflurane provides long-term protection against focal cerebral ischemia in the rat.

Authors:  Hiroaki Sakai; Huaxin Sheng; Robert B Yates; Kazuyoshi Ishida; Robert D Pearlstein; David S Warner
Journal:  Anesthesiology       Date:  2007-01       Impact factor: 7.892

3.  Neuroprotective effects of argon in an in vivo model of transient middle cerebral artery occlusion in rats.

Authors:  Yu-Mi Ryang; Astrid V Fahlenkamp; Rolf Rossaint; Dominik Wesp; Philip D Loetscher; Cordian Beyer; Mark Coburn
Journal:  Crit Care Med       Date:  2011-06       Impact factor: 7.598

4.  The noble gas argon modifies extracellular signal-regulated kinase 1/2 signaling in neurons and glial cells.

Authors:  Astrid V Fahlenkamp; Rolf Rossaint; Hajo Haase; Hussam Al Kassam; Yu-Mi Ryang; Cordian Beyer; Mark Coburn
Journal:  Eur J Pharmacol       Date:  2011-11-07       Impact factor: 4.432

5.  Delayed secondary phase of peri-infarct depolarizations after focal cerebral ischemia: relation to infarct growth and neuroprotection.

Authors:  Jed A Hartings; Michael L Rolli; X-C May Lu; Frank C Tortella
Journal:  J Neurosci       Date:  2003-12-17       Impact factor: 6.167

6.  Intraischemic nitrous oxide alters neither neurologic nor histologic outcome: a comparison with dizocilpine.

Authors:  Noriko Yokoo; Huaxin Sheng; Javier Mixco; H Mayumi Homi; Robert D Pearlstein; David S Warner
Journal:  Anesth Analg       Date:  2004-09       Impact factor: 5.108

7.  Admission body temperature predicts long-term mortality after acute stroke: the Copenhagen Stroke Study.

Authors:  L P Kammersgaard; H S Jørgensen; J A Rungby; J Reith; H Nakayama; U J Weber; J Houth; T S Olsen
Journal:  Stroke       Date:  2002-07       Impact factor: 7.914

Review 8.  Can restoring incomplete microcirculatory reperfusion improve stroke outcome after thrombolysis?

Authors:  Turgay Dalkara; Ethem Murat Arsava
Journal:  J Cereb Blood Flow Metab       Date:  2012-10-10       Impact factor: 6.200

9.  Ex vivo and in vivo neuroprotection induced by argon when given after an excitotoxic or ischemic insult.

Authors:  Hélène N David; Benoît Haelewyn; Mickael Degoulet; Denis G Colomb; Jean-Jacques Risso; Jacques H Abraini
Journal:  PLoS One       Date:  2012-02-22       Impact factor: 3.240

Review 10.  Reperfusion injury following cerebral ischemia: pathophysiology, MR imaging, and potential therapies.

Authors:  Jie Pan; Angelos-Aristeidis Konstas; Brian Bateman; Girolamo A Ortolano; John Pile-Spellman
Journal:  Neuroradiology       Date:  2006-12-20       Impact factor: 2.804

View more
  8 in total

Review 1.  Perioperative stroke: A perspective on challenges and opportunities for experimental treatment and diagnostic strategies.

Authors:  Xia Jin; Peiying Li; Dominik Michalski; Shen Li; Yueman Zhang; Jukka Jolkkonen; Lili Cui; Nadine Didwischus; Wei Xuan; Johannes Boltze
Journal:  CNS Neurosci Ther       Date:  2022-02-27       Impact factor: 5.243

2.  Timely and Appropriate Administration of Inhaled Argon Provides Better Outcomes for tMCAO Mice: A Controlled, Randomized, and Double-Blind Animal Study.

Authors:  Juan He; Ke Xue; Jiayi Liu; Jin-Hua Gu; Bin Peng; Lihua Xu; Guohua Wang; Zhenglin Jiang; Xia Li; Yunfeng Zhang
Journal:  Neurocrit Care       Date:  2022-02-08       Impact factor: 3.532

3.  Argon Inhalation for 24 h After Closed-Head Injury Does not Improve Recovery, Neuroinflammation, or Neurologic Outcome in Mice.

Authors:  Jennifer Creed; Viviana Cantillana-Riquelme; Bai Hui Yan; Shuang Ma; Dongmei Chu; Haichen Wang; Dennis A Turner; Daniel T Laskowitz; Ulrike Hoffmann
Journal:  Neurocrit Care       Date:  2020-09-21       Impact factor: 3.210

4.  Post-stroke treatment with argon preserved neurons and attenuated microglia/macrophage activation long-termly in a rat model of transient middle cerebral artery occlusion (tMCAO).

Authors:  Jingjin Liu; Michael Veldeman; Anke Höllig; Kay Nolte; Lisa Liebenstund; Antje Willuweit; Karl-Josef Langen; Rolf Rossaint; Mark Coburn
Journal:  Sci Rep       Date:  2022-01-13       Impact factor: 4.379

Review 5.  Noble Gases Therapy in Cardiocerebrovascular Diseases: The Novel Stars?

Authors:  Jiongshan Zhang; Wei Liu; Mingmin Bi; Jinwen Xu; Hongzhi Yang; Yaxing Zhang
Journal:  Front Cardiovasc Med       Date:  2022-03-16

6.  Three-Hour Argon Inhalation Has No Neuroprotective Effect after Open Traumatic Brain Injury in Rats.

Authors:  Viktoriya V Antonova; Denis N Silachev; Ivan A Ryzhkov; Konstantin N Lapin; Sergey N Kalabushev; Irina V Ostrova; Lydia A Varnakova; Oleg A Grebenchikov
Journal:  Brain Sci       Date:  2022-07-13

Review 7.  Neuroprotection by the noble gases argon and xenon as treatments for acquired brain injury: a preclinical systematic review and meta-analysis.

Authors:  Min Liang; Fatin Ahmad; Robert Dickinson
Journal:  Br J Anaesth       Date:  2022-06-07       Impact factor: 11.719

Review 8.  Update of the organoprotective properties of xenon and argon: from bench to beside.

Authors:  Roehl Anna; Rossaint Rolf; Coburn Mark
Journal:  Intensive Care Med Exp       Date:  2020-02-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.